Claim Window Now CLOSED

Cosequin Class Action Lawsuit

Updated
California dog owners claimed Nutramax marketed Cosequin's joint-health benefits with claims clinical science does not support. Nutramax denies it and settled for $11.5 million.
See settlements you can still claim
Beagle on a leash walking through a sunlit park – Cosequin dog supplements class action

What happens next with the Cosequin settlement

The claim deadline passed on July 20, 2026. New claims for this settlement are no longer being accepted.

The court approved the settlement on November 2, 2026. Payments are sent once that approval is final: after the time for anyone to appeal it runs out, or after any appeal ends.

Then the payments go out. The settlement administrator, the firm the court appointed to process claims, sends payments to eligible claimants once it has reviewed the claims. How long that takes varies from one settlement to the next.

Filed this claim with Chimo? The status of your claim is on the claims page in your account.

2026 Class Action Settlements > Cosequin Class Action

Cosequin Class Action Lawsuit

Justin Lytle and Christine Musthaler sued Nutramax Laboratories in federal court in California on May 3, 2019, on behalf of California consumers, alleging that the company misrepresented the joint-health benefits of its Cosequin-branded canine supplements. They allege that Nutramax's advertising and packaging — including claims that Cosequin enhances joint flexibility and mobility and helps dogs "climb stairs, rise, and jump" — was not supported by reliable science, and that claims about the active ingredients glucosamine and chondroitin had been refuted by peer-reviewed, randomized controlled clinical trials. Nutramax denies the allegations, and no court has decided who was right. The original complaint brought claims under California's Consumers Legal Remedies Act (CLRA, Cal. Civ. Code §§ 1750 et seq.) and False Advertising Law. The case is in the U.S. District Court for the Central District of California (Case No. 5:19-CV-00835-FMO-SP). The court certified a Rule 23(b)(3) California class under the CLRA on May 6, 2022; the Ninth Circuit affirmed certification in 2024 (Lytle v. Nutramax Laboratories, Inc., 114 F.4th 1011), and the U.S. Supreme Court denied Nutramax's cert petition. Class counsel are Adam A. Edwards of Milberg Coleman Bryson Phillips Grossman, PLLC and Matthew D. Schultz of Levin Papantonio Rafferty. The parties reached agreement after a mediation on April 10, 2025, ending nearly six years of litigation.

Lawsuit Name
Justin Lytle and Christine Musthaler v. Nutramax Laboratories, Inc. et al.
Court
U.S. District Court, Central District of California
Case Number
5:19-CV-00835-FMO-SP
Judge
Hon. Fernando M. Olguin
Plaintiffs
Justin Lytle, Christine Musthaler
Defendants
Nutramax Laboratories, Inc. et al.
Key Allegation
The lawsuit claims Nutramax misled California dog owners by marketing Cosequin's joint-health benefits with claims that clinical science does not support.

Cosequin Class Action Settlement - $11,500,000

Nutramax Laboratories has agreed to an $11.5 million non-reversionary settlement fund to resolve the Cosequin lawsuit.

According to the latest Cosequin settlement update, the fund equals 67.2% of the $17.1 million in estimated damages calculated by plaintiffs' expert (based on a 30% price-premium analysis). Eligible for Cosequin settlement coverage were all California residents who purchased any of seven specified canine Cosequin products for personal household use between May 3, 2016, and May 6, 2022: Cosequin DS Maximum Strength Chewable Tablets; Cosequin DS Maximum Strength Plus MSM Chewable Tablets; Cosequin Maximum Strength Plus MSM Chewable Tablets; Cosequin with MSM Chewable Tablets; Cosequin DS Maximum Strength Plus MSM Soft Chews; Cosequin Maximum Strength Plus MSM Soft Chews; and Cosequin with MSM Soft Chews.

As part of the Cosequin lawsuit settlement amount, Nutramax also agreed to injunctive relief: removing three claims from future packaging — "Mobility, Cartilage and Joint Health Support," "Supports Mobility for a Healthy Lifestyle," and "Use Cosequin to help your pet Climb stairs, Rise and Jump!" The fund pays eligible claimants, up to $7,500 in service awards to each named plaintiff, and up to 33.33% in attorneys' fees and costs; the settlement administrator, Epiq, is paid by Nutramax directly. Anything left in the net fund goes to Valor Service Dogs. The claim deadline was July 21, 2026, and the court granted final approval on November 2, 2026.

Claims closed: July 20, 2026

Dog Supplements Class Action Payout: $25 per unit (up to 6)

The settlement offered eligible claimants up to $25 per unit of qualifying Cosequin product purchased between May 3, 2016, and May 6, 2022, capped at $150 (six units) per household — and importantly, no proof of purchase was required.

Each household (defined as all persons at the same physical address) could submit only one claim form. If total valid claims exceed the net fund after fees and service awards, payments are reduced on a pro rata basis automatically, with no re-submission needed. Class members could elect payment via Zelle (email or phone number) or ACH bank transfer (routing and account number); those who preferred mail could choose a physical check.

What an eligible claim is worth depends on units claimed and total claim volume: up to $25 for one unit and up to $150 for six or more. The court granted final approval on November 2, 2026. Payments are made to eligible claimants once that approval is final and any appeals conclude. Questions about a payment go to the settlement administrator at 1-888-899-7783.

Supplement False Advertising Class Action Settlements

Class action over false ingredient/quality marketing claims on Blue Buffalo pet food
$200
Multi-state class action alleging Premier Nutrition deceptively marketed Joint Juice glucosamine drinks as supporting joint health when peer-reviewed science did not support those claims
$90.00
Average Payouts

Dog Supplements Class Action Eligibility

Qualifying Products

Product

Covered

Cosequin DS Maximum Strength Chewable Tablets

✓

Cosequin DS Maximum Strength Plus MSM Chewable Tablets

✓

Cosequin Maximum Strength Plus MSM Chewable Tablets

✓

Cosequin with MSM Chewable Tablets

✓

Cosequin DS Maximum Strength Plus MSM Soft Chews

✓

Cosequin Maximum Strength Plus MSM Soft Chews

✓

Cosequin with MSM Soft Chews

✓

The class is California-only. Even though Nutramax sells Cosequin nationwide, residents of every other state are excluded from this settlement. The class was certified under California's Consumers Legal Remedies Act, so people living outside California were not class members.

The lawsuit claims Nutramax misrepresented the joint-health benefits of its Cosequin canine supplements; Nutramax denies it, and the court did not decide who was right. Nutramax agreed to pay $11.5 million to settle. Cosequin class action claimants had to meet all of the following Cosequin class action eligibility conditions:

You lived in California at the time of purchase.
You purchased one or more qualifying canine Cosequin products between May 3, 2016, and May 6, 2022.
You purchased them for personal household pet use, not for resale or other business purpose.
You are not an officer, director, agent, affiliate, or employee of Nutramax (past or present).

FAQ

The court certified the class under California's Consumers Legal Remedies Act (CLRA), for people living in California, and the Ninth Circuit affirmed that certification in 2024. The settlement class is likewise limited to people living in California, so residents of other states are not covered by this settlement.

Plaintiffs allege that peer-reviewed, randomized controlled clinical trials refute the claim that glucosamine and chondroitin meaningfully support canine joint flexibility, mobility, or cartilage. Both named plaintiffs reported their dogs showed no improvement after using Cosequin.

No. There was no proof-of-purchase requirement. Claimants certified on the claim form that they lived in California and purchased qualifying Cosequin products during the class period. The settlement administrator reserves the right to verify claims.

Nutramax agreed to remove three specific phrases from future packaging: "Mobility, Cartilage and Joint Health Support," "Supports Mobility for a Healthy Lifestyle," and "Use Cosequin to help your pet Climb stairs, Rise and Jump!" The change is part of the settlement, not a court finding.

Class counsel (Milberg Coleman Bryson Phillips Grossman and Levin Papantonio Rafferty) requested up to 33.33% of the $11.5 million fund — roughly $3.83 million — for fees and costs. The court could award less.

Each named plaintiff may receive up to $7,500 in service awards for more than six years of active participation, including depositions, document production, and ongoing involvement with counsel.

Claimants could elect Zelle (by email or phone) or a direct ACH bank transfer, or request a physical check. Digital payments usually arrive sooner than mailed checks, though that is a tendency rather than a rule, and the administrator is not responsible for mail delays.

Plaintiffs' damages expert used a conjoint analysis to estimate a 25% to 35% price premium; applying 30%, class counsel put California damages at $17,112,007. The $11.5 million fund is 67.2% of that. The court compared it with approved settlements worth 30% of estimated damages or less.

Possibly. If total valid claims exceed the fund (after fees and service awards), every eligible claimant's payment is reduced pro rata. The adjustment is automatic, so you do not need to refile. The settlement is non-reversionary: money left in the net fund goes to Valor Service Dogs, not back to Nutramax.

Owners were still eligible to claim. The court has not made any determination of wrongdoing; Nutramax denies the allegations. Eligibility turned on whether the owner lived in California and purchased a qualifying product during the class period — not on whether the product worked for their pet.

Sources

These are the court's own records for this case. They are hosted here unchanged, so you can check anything on this page against the documents themselves.

The full case file is on the court docket: view the docket.

CHIMO
Sign up for updates on new lawsuits
and unclaimed money opportunities
© 2026 Chimo AI Inc. - All rights reserved.
About Us Contact Us Privacy Policy Terms and Conditions